Thomas Vigier has extensive experience in the healthcare and pharmaceutical sectors, having held various leadership roles over the years. Thomas served as Marketing Manager - Primary Care at Bayer Healthcare from April 2006 to January 2012, followed by a position as Product Manager at Fournier Pharma from 2000 to 2002. Afterward, at Solvay Pharmaceuticals, Thomas worked as Product Manager from 2002 to 2006. Thomas then joined Bayer Pharmaceuticals, taking on roles such as Market Access Strategy Manager - Oncology/Hemophilia and Regional Sales Manager - Cardiology between May 2015 and September 2017. From September 2017 to January 2021, Thomas was the Commercial Excellence Head at Bayer Animal Health before transitioning to Elanco as O2C transformation Leader from February 2021 to May 2024. Currently, Thomas is the Directeur des opérations commerciales at Galderma since June 2024. Thomas holds an MBA from Burgundy Business School, France (1991-1994) and obtained a PMP certification from the Project Management Institute (1994-2024).
This person is not in the org chart
This person is not in any teams
This person is not in any offices